nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—KCNMA1—epilepsy syndrome	0.22	0.552	CbGaD
Bendroflumethiazide—CA4—epilepsy syndrome	0.178	0.448	CbGaD
Bendroflumethiazide—CA1—Lacosamide—epilepsy syndrome	0.0529	0.128	CbGbCtD
Bendroflumethiazide—CA4—Lacosamide—epilepsy syndrome	0.0497	0.12	CbGbCtD
Bendroflumethiazide—CA2—Lacosamide—epilepsy syndrome	0.0457	0.11	CbGbCtD
Bendroflumethiazide—CA1—Acetazolamide—epilepsy syndrome	0.0364	0.088	CbGbCtD
Bendroflumethiazide—CA4—Acetazolamide—epilepsy syndrome	0.0342	0.0827	CbGbCtD
Bendroflumethiazide—CA1—Zonisamide—epilepsy syndrome	0.0337	0.0814	CbGbCtD
Bendroflumethiazide—CA4—Zonisamide—epilepsy syndrome	0.0317	0.0765	CbGbCtD
Bendroflumethiazide—CA2—Acetazolamide—epilepsy syndrome	0.0315	0.076	CbGbCtD
Bendroflumethiazide—CA2—Zonisamide—epilepsy syndrome	0.0291	0.0704	CbGbCtD
Bendroflumethiazide—CA1—Topiramate—epilepsy syndrome	0.0245	0.0593	CbGbCtD
Bendroflumethiazide—CA4—Topiramate—epilepsy syndrome	0.0231	0.0558	CbGbCtD
Bendroflumethiazide—CA2—Topiramate—epilepsy syndrome	0.0212	0.0513	CbGbCtD
Bendroflumethiazide—KCNMA1—ganglion—epilepsy syndrome	0.002	0.076	CbGeAlD
Bendroflumethiazide—KCNMA1—hindbrain—epilepsy syndrome	0.00151	0.0576	CbGeAlD
Bendroflumethiazide—CA4—ganglion—epilepsy syndrome	0.00119	0.0451	CbGeAlD
Bendroflumethiazide—CA4—hindbrain—epilepsy syndrome	0.000899	0.0342	CbGeAlD
Bendroflumethiazide—KCNMA1—brainstem—epilepsy syndrome	0.000868	0.033	CbGeAlD
Bendroflumethiazide—KCNMA1—forebrain—epilepsy syndrome	0.000838	0.0319	CbGeAlD
Bendroflumethiazide—TPMT—telencephalon—epilepsy syndrome	0.000828	0.0315	CbGeAlD
Bendroflumethiazide—KCNMA1—telencephalon—epilepsy syndrome	0.00077	0.0293	CbGeAlD
Bendroflumethiazide—CA2—hindbrain—epilepsy syndrome	0.000745	0.0284	CbGeAlD
Bendroflumethiazide—TPMT—medulla oblongata—epilepsy syndrome	0.00065	0.0247	CbGeAlD
Bendroflumethiazide—CA1—forebrain—epilepsy syndrome	0.000636	0.0242	CbGeAlD
Bendroflumethiazide—TPMT—midbrain—epilepsy syndrome	0.000594	0.0226	CbGeAlD
Bendroflumethiazide—CA1—telencephalon—epilepsy syndrome	0.000585	0.0223	CbGeAlD
Bendroflumethiazide—TPMT—spinal cord—epilepsy syndrome	0.00058	0.0221	CbGeAlD
Bendroflumethiazide—KCNMA1—midbrain—epilepsy syndrome	0.000553	0.021	CbGeAlD
Bendroflumethiazide—TPMT—head—epilepsy syndrome	0.000515	0.0196	CbGeAlD
Bendroflumethiazide—CA4—brainstem—epilepsy syndrome	0.000515	0.0196	CbGeAlD
Bendroflumethiazide—CA4—forebrain—epilepsy syndrome	0.000497	0.0189	CbGeAlD
Bendroflumethiazide—TPMT—nervous system—epilepsy syndrome	0.000489	0.0186	CbGeAlD
Bendroflumethiazide—KCNMA1—head—epilepsy syndrome	0.00048	0.0183	CbGeAlD
Bendroflumethiazide—Hydroflumethiazide—KCNMA1—epilepsy syndrome	0.000473	0.161	CrCbGaD
Bendroflumethiazide—TPMT—central nervous system—epilepsy syndrome	0.00047	0.0179	CbGeAlD
Bendroflumethiazide—Hydrochlorothiazide—KCNMA1—epilepsy syndrome	0.000461	0.157	CrCbGaD
Bendroflumethiazide—TPMT—cerebellum—epilepsy syndrome	0.00046	0.0175	CbGeAlD
Bendroflumethiazide—Benzthiazide—CA4—epilepsy syndrome	0.000458	0.156	CrCbGaD
Bendroflumethiazide—Cyclothiazide—CA4—epilepsy syndrome	0.000458	0.156	CrCbGaD
Bendroflumethiazide—CA4—telencephalon—epilepsy syndrome	0.000457	0.0174	CbGeAlD
Bendroflumethiazide—KCNMA1—nervous system—epilepsy syndrome	0.000455	0.0173	CbGeAlD
Bendroflumethiazide—KCNMA1—central nervous system—epilepsy syndrome	0.000438	0.0167	CbGeAlD
Bendroflumethiazide—KCNMA1—cerebellum—epilepsy syndrome	0.000428	0.0163	CbGeAlD
Bendroflumethiazide—CA2—brainstem—epilepsy syndrome	0.000427	0.0163	CbGeAlD
Bendroflumethiazide—CA2—forebrain—epilepsy syndrome	0.000412	0.0157	CbGeAlD
Bendroflumethiazide—CA1—spinal cord—epilepsy syndrome	0.00041	0.0156	CbGeAlD
Bendroflumethiazide—Hydroflumethiazide—CA4—epilepsy syndrome	0.000384	0.131	CrCbGaD
Bendroflumethiazide—CA2—telencephalon—epilepsy syndrome	0.000379	0.0144	CbGeAlD
Bendroflumethiazide—Hydrochlorothiazide—CA4—epilepsy syndrome	0.000374	0.127	CrCbGaD
Bendroflumethiazide—TPMT—brain—epilepsy syndrome	0.000373	0.0142	CbGeAlD
Bendroflumethiazide—CA1—head—epilepsy syndrome	0.000364	0.0139	CbGeAlD
Bendroflumethiazide—CA4—medulla oblongata—epilepsy syndrome	0.000359	0.0137	CbGeAlD
Bendroflumethiazide—KCNMA1—brain—epilepsy syndrome	0.000348	0.0132	CbGeAlD
Bendroflumethiazide—CA1—nervous system—epilepsy syndrome	0.000345	0.0131	CbGeAlD
Bendroflumethiazide—Trichlormethiazide—CA4—epilepsy syndrome	0.000333	0.113	CrCbGaD
Bendroflumethiazide—CA1—central nervous system—epilepsy syndrome	0.000332	0.0127	CbGeAlD
Bendroflumethiazide—CA4—midbrain—epilepsy syndrome	0.000328	0.0125	CbGeAlD
Bendroflumethiazide—CA4—spinal cord—epilepsy syndrome	0.00032	0.0122	CbGeAlD
Bendroflumethiazide—CA2—medulla oblongata—epilepsy syndrome	0.000298	0.0113	CbGeAlD
Bendroflumethiazide—CA4—head—epilepsy syndrome	0.000285	0.0108	CbGeAlD
Bendroflumethiazide—CA2—midbrain—epilepsy syndrome	0.000272	0.0104	CbGeAlD
Bendroflumethiazide—CA4—nervous system—epilepsy syndrome	0.00027	0.0103	CbGeAlD
Bendroflumethiazide—CA2—spinal cord—epilepsy syndrome	0.000266	0.0101	CbGeAlD
Bendroflumethiazide—CA1—brain—epilepsy syndrome	0.000264	0.01	CbGeAlD
Bendroflumethiazide—CA4—central nervous system—epilepsy syndrome	0.00026	0.00989	CbGeAlD
Bendroflumethiazide—CA4—cerebellum—epilepsy syndrome	0.000254	0.00967	CbGeAlD
Bendroflumethiazide—CA2—head—epilepsy syndrome	0.000236	0.00899	CbGeAlD
Bendroflumethiazide—CA2—nervous system—epilepsy syndrome	0.000224	0.00852	CbGeAlD
Bendroflumethiazide—CA2—central nervous system—epilepsy syndrome	0.000215	0.0082	CbGeAlD
Bendroflumethiazide—CA2—cerebellum—epilepsy syndrome	0.000211	0.00802	CbGeAlD
Bendroflumethiazide—CA4—brain—epilepsy syndrome	0.000206	0.00785	CbGeAlD
Bendroflumethiazide—Hypokalaemia—Pregabalin—epilepsy syndrome	0.000205	0.00229	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Pregabalin—epilepsy syndrome	0.000203	0.00227	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Topiramate—epilepsy syndrome	0.0002	0.00224	CcSEcCtD
Bendroflumethiazide—Vomiting—Trimethadione—epilepsy syndrome	0.000199	0.00223	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Clonazepam—epilepsy syndrome	0.000198	0.00222	CcSEcCtD
Bendroflumethiazide—Polyuria—Topiramate—epilepsy syndrome	0.000198	0.00221	CcSEcCtD
Bendroflumethiazide—Rash—Trimethadione—epilepsy syndrome	0.000198	0.00221	CcSEcCtD
Bendroflumethiazide—Dermatitis—Trimethadione—epilepsy syndrome	0.000198	0.00221	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Phenytoin—epilepsy syndrome	0.000197	0.0022	CcSEcCtD
Bendroflumethiazide—Asthenia—Rufinamide—epilepsy syndrome	0.000196	0.00219	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Levetiracetam—epilepsy syndrome	0.000195	0.00218	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Topiramate—epilepsy syndrome	0.000194	0.00217	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Acetazolamide—epilepsy syndrome	0.000192	0.00216	CcSEcCtD
Bendroflumethiazide—Hypotension—Propofol—epilepsy syndrome	0.000192	0.00215	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Pregabalin—epilepsy syndrome	0.000191	0.00214	CcSEcCtD
Bendroflumethiazide—Anorexia—Levetiracetam—epilepsy syndrome	0.000189	0.00212	CcSEcCtD
Bendroflumethiazide—Hypotension—Midazolam—epilepsy syndrome	0.000188	0.00211	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Fosphenytoin—epilepsy syndrome	0.000188	0.0021	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Carbamazepine—epilepsy syndrome	0.000188	0.0021	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Rufinamide—epilepsy syndrome	0.000187	0.00209	CcSEcCtD
Bendroflumethiazide—Nausea—Trimethadione—epilepsy syndrome	0.000186	0.00209	CcSEcCtD
Bendroflumethiazide—Asthenia—Lacosamide—epilepsy syndrome	0.000184	0.00206	CcSEcCtD
Bendroflumethiazide—Dizziness—Phenobarbital—epilepsy syndrome	0.000184	0.00206	CcSEcCtD
Bendroflumethiazide—Anorexia—Fosphenytoin—epilepsy syndrome	0.000183	0.00205	CcSEcCtD
Bendroflumethiazide—Thirst—Topiramate—epilepsy syndrome	0.000182	0.00204	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Lamotrigine—epilepsy syndrome	0.000181	0.00203	CcSEcCtD
Bendroflumethiazide—Dizziness—Rufinamide—epilepsy syndrome	0.00018	0.00202	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Diazepam—epilepsy syndrome	0.00018	0.00202	CcSEcCtD
Bendroflumethiazide—Purpura—Topiramate—epilepsy syndrome	0.00018	0.00202	CcSEcCtD
Bendroflumethiazide—Hypotension—Fosphenytoin—epilepsy syndrome	0.000179	0.00201	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Pregabalin—epilepsy syndrome	0.000179	0.00201	CcSEcCtD
Bendroflumethiazide—Asthenia—Clobazam—epilepsy syndrome	0.000178	0.002	CcSEcCtD
Bendroflumethiazide—Vomiting—Phenobarbital—epilepsy syndrome	0.000177	0.00198	CcSEcCtD
Bendroflumethiazide—Anorexia—Diazepam—epilepsy syndrome	0.000175	0.00196	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Lacosamide—epilepsy syndrome	0.000175	0.00196	CcSEcCtD
Bendroflumethiazide—Rash—Phenobarbital—epilepsy syndrome	0.000175	0.00196	CcSEcCtD
Bendroflumethiazide—Dermatitis—Phenobarbital—epilepsy syndrome	0.000175	0.00196	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Gabapentin—epilepsy syndrome	0.000175	0.00196	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Felbamate—epilepsy syndrome	0.000174	0.00195	CcSEcCtD
Bendroflumethiazide—Vomiting—Rufinamide—epilepsy syndrome	0.000173	0.00194	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Levetiracetam—epilepsy syndrome	0.000173	0.00193	CcSEcCtD
Bendroflumethiazide—Constipation—Midazolam—epilepsy syndrome	0.000172	0.00193	CcSEcCtD
Bendroflumethiazide—Hypotension—Diazepam—epilepsy syndrome	0.000172	0.00193	CcSEcCtD
Bendroflumethiazide—Rash—Rufinamide—epilepsy syndrome	0.000172	0.00192	CcSEcCtD
Bendroflumethiazide—Dermatitis—Rufinamide—epilepsy syndrome	0.000172	0.00192	CcSEcCtD
Bendroflumethiazide—CA2—brain—epilepsy syndrome	0.000171	0.00651	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000171	0.00191	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Clobazam—epilepsy syndrome	0.00017	0.0019	CcSEcCtD
Bendroflumethiazide—Constipation—Levetiracetam—epilepsy syndrome	0.00017	0.0019	CcSEcCtD
Bendroflumethiazide—Anorexia—Felbamate—epilepsy syndrome	0.00017	0.0019	CcSEcCtD
Bendroflumethiazide—Dizziness—Lacosamide—epilepsy syndrome	0.000169	0.0019	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Fosphenytoin—epilepsy syndrome	0.000167	0.00187	CcSEcCtD
Bendroflumethiazide—Hypotension—Felbamate—epilepsy syndrome	0.000166	0.00186	CcSEcCtD
Bendroflumethiazide—Anorexia—Zonisamide—epilepsy syndrome	0.000166	0.00186	CcSEcCtD
Bendroflumethiazide—Nausea—Phenobarbital—epilepsy syndrome	0.000165	0.00185	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000165	0.00184	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.000164	0.00184	CcSEcCtD
Bendroflumethiazide—Dizziness—Clobazam—epilepsy syndrome	0.000164	0.00184	CcSEcCtD
Bendroflumethiazide—Constipation—Fosphenytoin—epilepsy syndrome	0.000164	0.00184	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000163	0.00183	CcSEcCtD
Bendroflumethiazide—Hypotension—Zonisamide—epilepsy syndrome	0.000163	0.00182	CcSEcCtD
Bendroflumethiazide—Vomiting—Lacosamide—epilepsy syndrome	0.000163	0.00182	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000163	0.00182	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000163	0.00182	CcSEcCtD
Bendroflumethiazide—Nausea—Rufinamide—epilepsy syndrome	0.000162	0.00181	CcSEcCtD
Bendroflumethiazide—Rash—Lacosamide—epilepsy syndrome	0.000161	0.00181	CcSEcCtD
Bendroflumethiazide—Dermatitis—Lacosamide—epilepsy syndrome	0.000161	0.00181	CcSEcCtD
Bendroflumethiazide—Anorexia—Clonazepam—epilepsy syndrome	0.00016	0.00179	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Diazepam—epilepsy syndrome	0.00016	0.00179	CcSEcCtD
Bendroflumethiazide—Constipation—Vigabatrin—epilepsy syndrome	0.00016	0.00179	CcSEcCtD
Bendroflumethiazide—Anorexia—Phenytoin—epilepsy syndrome	0.000159	0.00178	CcSEcCtD
Bendroflumethiazide—Asthenia—Acetazolamide—epilepsy syndrome	0.000159	0.00178	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000159	0.00178	CcSEcCtD
Bendroflumethiazide—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000158	0.00177	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Topiramate—epilepsy syndrome	0.000158	0.00177	CcSEcCtD
Bendroflumethiazide—Vomiting—Clobazam—epilepsy syndrome	0.000158	0.00177	CcSEcCtD
Bendroflumethiazide—Constipation—Diazepam—epilepsy syndrome	0.000157	0.00176	CcSEcCtD
Bendroflumethiazide—Hypotension—Clonazepam—epilepsy syndrome	0.000157	0.00176	CcSEcCtD
Bendroflumethiazide—Rash—Clobazam—epilepsy syndrome	0.000157	0.00175	CcSEcCtD
Bendroflumethiazide—Dermatitis—Clobazam—epilepsy syndrome	0.000157	0.00175	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000156	0.00175	CcSEcCtD
Bendroflumethiazide—Hypotension—Phenytoin—epilepsy syndrome	0.000156	0.00175	CcSEcCtD
Bendroflumethiazide—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000155	0.00174	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Felbamate—epilepsy syndrome	0.000155	0.00173	CcSEcCtD
Bendroflumethiazide—Constipation—Felbamate—epilepsy syndrome	0.000152	0.00171	CcSEcCtD
Bendroflumethiazide—Nausea—Lacosamide—epilepsy syndrome	0.000152	0.0017	CcSEcCtD
Bendroflumethiazide—Anorexia—Carbamazepine—epilepsy syndrome	0.000152	0.0017	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Zonisamide—epilepsy syndrome	0.000152	0.0017	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000152	0.0017	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000151	0.00169	CcSEcCtD
Bendroflumethiazide—Constipation—Zonisamide—epilepsy syndrome	0.000149	0.00167	CcSEcCtD
Bendroflumethiazide—Hypotension—Carbamazepine—epilepsy syndrome	0.000149	0.00167	CcSEcCtD
Bendroflumethiazide—Nausea—Clobazam—epilepsy syndrome	0.000148	0.00165	CcSEcCtD
Bendroflumethiazide—Asthenia—Propofol—epilepsy syndrome	0.000148	0.00165	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Topiramate—epilepsy syndrome	0.000147	0.00165	CcSEcCtD
Bendroflumethiazide—Anorexia—Lamotrigine—epilepsy syndrome	0.000147	0.00164	CcSEcCtD
Bendroflumethiazide—Dizziness—Acetazolamide—epilepsy syndrome	0.000146	0.00164	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Clonazepam—epilepsy syndrome	0.000146	0.00164	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Phenytoin—epilepsy syndrome	0.000145	0.00162	CcSEcCtD
Bendroflumethiazide—Asthenia—Midazolam—epilepsy syndrome	0.000144	0.00162	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000144	0.00162	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000144	0.00161	CcSEcCtD
Bendroflumethiazide—Constipation—Clonazepam—epilepsy syndrome	0.000144	0.00161	CcSEcCtD
Bendroflumethiazide—Constipation—Phenytoin—epilepsy syndrome	0.000143	0.0016	CcSEcCtD
Bendroflumethiazide—Asthenia—Levetiracetam—epilepsy syndrome	0.000143	0.0016	CcSEcCtD
Bendroflumethiazide—Constipation—Oxcarbazepine—epilepsy syndrome	0.000142	0.00159	CcSEcCtD
Bendroflumethiazide—Vomiting—Acetazolamide—epilepsy syndrome	0.000141	0.00158	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Propofol—epilepsy syndrome	0.000141	0.00158	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000139	0.00155	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000138	0.00155	CcSEcCtD
Bendroflumethiazide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000138	0.00154	CcSEcCtD
Bendroflumethiazide—Constipation—Carbamazepine—epilepsy syndrome	0.000136	0.00153	CcSEcCtD
Bendroflumethiazide—Dizziness—Propofol—epilepsy syndrome	0.000136	0.00152	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000136	0.00152	CcSEcCtD
Bendroflumethiazide—Asthenia—Vigabatrin—epilepsy syndrome	0.000134	0.0015	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000134	0.0015	CcSEcCtD
Bendroflumethiazide—Dizziness—Midazolam—epilepsy syndrome	0.000133	0.00149	CcSEcCtD
Bendroflumethiazide—Asthenia—Diazepam—epilepsy syndrome	0.000132	0.00148	CcSEcCtD
Bendroflumethiazide—Constipation—Lamotrigine—epilepsy syndrome	0.000132	0.00147	CcSEcCtD
Bendroflumethiazide—Nausea—Acetazolamide—epilepsy syndrome	0.000132	0.00147	CcSEcCtD
Bendroflumethiazide—Dizziness—Levetiracetam—epilepsy syndrome	0.000131	0.00147	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000131	0.00147	CcSEcCtD
Bendroflumethiazide—Vomiting—Propofol—epilepsy syndrome	0.000131	0.00146	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Pregabalin—epilepsy syndrome	0.00013	0.00146	CcSEcCtD
Bendroflumethiazide—Rash—Propofol—epilepsy syndrome	0.00013	0.00145	CcSEcCtD
Bendroflumethiazide—Dermatitis—Propofol—epilepsy syndrome	0.00013	0.00145	CcSEcCtD
Bendroflumethiazide—Vomiting—Midazolam—epilepsy syndrome	0.000128	0.00143	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000128	0.00143	CcSEcCtD
Bendroflumethiazide—Asthenia—Felbamate—epilepsy syndrome	0.000128	0.00143	CcSEcCtD
Bendroflumethiazide—Rash—Midazolam—epilepsy syndrome	0.000127	0.00142	CcSEcCtD
Bendroflumethiazide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000127	0.00142	CcSEcCtD
Bendroflumethiazide—Dermatitis—Midazolam—epilepsy syndrome	0.000127	0.00142	CcSEcCtD
Bendroflumethiazide—Vomiting—Levetiracetam—epilepsy syndrome	0.000126	0.00141	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Diazepam—epilepsy syndrome	0.000126	0.00141	CcSEcCtD
Bendroflumethiazide—Rash—Levetiracetam—epilepsy syndrome	0.000125	0.0014	CcSEcCtD
Bendroflumethiazide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000125	0.0014	CcSEcCtD
Bendroflumethiazide—Asthenia—Zonisamide—epilepsy syndrome	0.000125	0.0014	CcSEcCtD
Bendroflumethiazide—Dizziness—Vigabatrin—epilepsy syndrome	0.000124	0.00138	CcSEcCtD
Bendroflumethiazide—Nausea—Propofol—epilepsy syndrome	0.000122	0.00137	CcSEcCtD
Bendroflumethiazide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000122	0.00137	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Felbamate—epilepsy syndrome	0.000122	0.00136	CcSEcCtD
Bendroflumethiazide—Dizziness—Diazepam—epilepsy syndrome	0.000122	0.00136	CcSEcCtD
Bendroflumethiazide—Rash—Fosphenytoin—epilepsy syndrome	0.000121	0.00135	CcSEcCtD
Bendroflumethiazide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000121	0.00135	CcSEcCtD
Bendroflumethiazide—Asthenia—Clonazepam—epilepsy syndrome	0.000121	0.00135	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.00012	0.00134	CcSEcCtD
Bendroflumethiazide—Asthenia—Phenytoin—epilepsy syndrome	0.00012	0.00134	CcSEcCtD
Bendroflumethiazide—Nausea—Midazolam—epilepsy syndrome	0.00012	0.00134	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Gabapentin—epilepsy syndrome	0.000119	0.00134	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Zonisamide—epilepsy syndrome	0.000119	0.00134	CcSEcCtD
Bendroflumethiazide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000119	0.00133	CcSEcCtD
Bendroflumethiazide—Vomiting—Vigabatrin—epilepsy syndrome	0.000119	0.00133	CcSEcCtD
Bendroflumethiazide—Nausea—Levetiracetam—epilepsy syndrome	0.000118	0.00132	CcSEcCtD
Bendroflumethiazide—Rash—Vigabatrin—epilepsy syndrome	0.000118	0.00132	CcSEcCtD
Bendroflumethiazide—Dizziness—Felbamate—epilepsy syndrome	0.000118	0.00132	CcSEcCtD
Bendroflumethiazide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000118	0.00132	CcSEcCtD
Bendroflumethiazide—Vomiting—Diazepam—epilepsy syndrome	0.000117	0.00131	CcSEcCtD
Bendroflumethiazide—Anorexia—Valproic Acid—epilepsy syndrome	0.000117	0.00131	CcSEcCtD
Bendroflumethiazide—Rash—Diazepam—epilepsy syndrome	0.000116	0.0013	CcSEcCtD
Bendroflumethiazide—Dermatitis—Diazepam—epilepsy syndrome	0.000116	0.0013	CcSEcCtD
Bendroflumethiazide—Dizziness—Zonisamide—epilepsy syndrome	0.000115	0.00129	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000115	0.00129	CcSEcCtD
Bendroflumethiazide—Hypotension—Valproic Acid—epilepsy syndrome	0.000114	0.00128	CcSEcCtD
Bendroflumethiazide—Asthenia—Carbamazepine—epilepsy syndrome	0.000114	0.00128	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Phenytoin—epilepsy syndrome	0.000114	0.00128	CcSEcCtD
Bendroflumethiazide—Nausea—Fosphenytoin—epilepsy syndrome	0.000114	0.00128	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000114	0.00127	CcSEcCtD
Bendroflumethiazide—Vomiting—Felbamate—epilepsy syndrome	0.000113	0.00127	CcSEcCtD
Bendroflumethiazide—Rash—Felbamate—epilepsy syndrome	0.000112	0.00126	CcSEcCtD
Bendroflumethiazide—Dermatitis—Felbamate—epilepsy syndrome	0.000112	0.00126	CcSEcCtD
Bendroflumethiazide—Dizziness—Clonazepam—epilepsy syndrome	0.000111	0.00124	CcSEcCtD
Bendroflumethiazide—Nausea—Vigabatrin—epilepsy syndrome	0.000111	0.00124	CcSEcCtD
Bendroflumethiazide—Vomiting—Zonisamide—epilepsy syndrome	0.000111	0.00124	CcSEcCtD
Bendroflumethiazide—Asthenia—Lamotrigine—epilepsy syndrome	0.00011	0.00124	CcSEcCtD
Bendroflumethiazide—Dizziness—Phenytoin—epilepsy syndrome	0.00011	0.00124	CcSEcCtD
Bendroflumethiazide—Rash—Zonisamide—epilepsy syndrome	0.00011	0.00123	CcSEcCtD
Bendroflumethiazide—Dermatitis—Zonisamide—epilepsy syndrome	0.00011	0.00123	CcSEcCtD
Bendroflumethiazide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00011	0.00123	CcSEcCtD
Bendroflumethiazide—Nausea—Diazepam—epilepsy syndrome	0.000109	0.00122	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000109	0.00122	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000108	0.00121	CcSEcCtD
Bendroflumethiazide—Vomiting—Clonazepam—epilepsy syndrome	0.000107	0.0012	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000106	0.00119	CcSEcCtD
Bendroflumethiazide—Vomiting—Phenytoin—epilepsy syndrome	0.000106	0.00119	CcSEcCtD
Bendroflumethiazide—Rash—Clonazepam—epilepsy syndrome	0.000106	0.00119	CcSEcCtD
Bendroflumethiazide—Dermatitis—Clonazepam—epilepsy syndrome	0.000106	0.00119	CcSEcCtD
Bendroflumethiazide—Nausea—Felbamate—epilepsy syndrome	0.000106	0.00118	CcSEcCtD
Bendroflumethiazide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000106	0.00118	CcSEcCtD
Bendroflumethiazide—Anorexia—Pregabalin—epilepsy syndrome	0.000105	0.00118	CcSEcCtD
Bendroflumethiazide—Dizziness—Carbamazepine—epilepsy syndrome	0.000105	0.00118	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000105	0.00118	CcSEcCtD
Bendroflumethiazide—Rash—Phenytoin—epilepsy syndrome	0.000105	0.00118	CcSEcCtD
Bendroflumethiazide—Dermatitis—Phenytoin—epilepsy syndrome	0.000105	0.00118	CcSEcCtD
Bendroflumethiazide—Rash—Oxcarbazepine—epilepsy syndrome	0.000105	0.00117	CcSEcCtD
Bendroflumethiazide—Constipation—Valproic Acid—epilepsy syndrome	0.000105	0.00117	CcSEcCtD
Bendroflumethiazide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000105	0.00117	CcSEcCtD
Bendroflumethiazide—Nausea—Zonisamide—epilepsy syndrome	0.000104	0.00116	CcSEcCtD
Bendroflumethiazide—Hypotension—Pregabalin—epilepsy syndrome	0.000103	0.00116	CcSEcCtD
Bendroflumethiazide—Dizziness—Lamotrigine—epilepsy syndrome	0.000102	0.00114	CcSEcCtD
Bendroflumethiazide—Vomiting—Carbamazepine—epilepsy syndrome	0.000101	0.00113	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Topiramate—epilepsy syndrome	0.000101	0.00113	CcSEcCtD
Bendroflumethiazide—Rash—Carbamazepine—epilepsy syndrome	0.0001	0.00112	CcSEcCtD
Bendroflumethiazide—Dermatitis—Carbamazepine—epilepsy syndrome	0.0001	0.00112	CcSEcCtD
Bendroflumethiazide—Nausea—Clonazepam—epilepsy syndrome	9.98e-05	0.00112	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.93e-05	0.00111	CcSEcCtD
Bendroflumethiazide—Nausea—Phenytoin—epilepsy syndrome	9.91e-05	0.00111	CcSEcCtD
Bendroflumethiazide—Nausea—Oxcarbazepine—epilepsy syndrome	9.86e-05	0.0011	CcSEcCtD
Bendroflumethiazide—Vomiting—Lamotrigine—epilepsy syndrome	9.79e-05	0.0011	CcSEcCtD
Bendroflumethiazide—Rash—Lamotrigine—epilepsy syndrome	9.71e-05	0.00109	CcSEcCtD
Bendroflumethiazide—Dermatitis—Lamotrigine—epilepsy syndrome	9.7e-05	0.00109	CcSEcCtD
Bendroflumethiazide—Anorexia—Gabapentin—epilepsy syndrome	9.67e-05	0.00108	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Pregabalin—epilepsy syndrome	9.62e-05	0.00108	CcSEcCtD
Bendroflumethiazide—Hypotension—Gabapentin—epilepsy syndrome	9.48e-05	0.00106	CcSEcCtD
Bendroflumethiazide—Nausea—Carbamazepine—epilepsy syndrome	9.46e-05	0.00106	CcSEcCtD
Bendroflumethiazide—Constipation—Pregabalin—epilepsy syndrome	9.46e-05	0.00106	CcSEcCtD
Bendroflumethiazide—Nausea—Lamotrigine—epilepsy syndrome	9.15e-05	0.00102	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gabapentin—epilepsy syndrome	8.82e-05	0.000987	CcSEcCtD
Bendroflumethiazide—Asthenia—Valproic Acid—epilepsy syndrome	8.78e-05	0.000983	CcSEcCtD
Bendroflumethiazide—Constipation—Gabapentin—epilepsy syndrome	8.67e-05	0.000971	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Valproic Acid—epilepsy syndrome	8.37e-05	0.000937	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Topiramate—epilepsy syndrome	8.36e-05	0.000936	CcSEcCtD
Bendroflumethiazide—Anorexia—Topiramate—epilepsy syndrome	8.14e-05	0.000911	CcSEcCtD
Bendroflumethiazide—Dizziness—Valproic Acid—epilepsy syndrome	8.09e-05	0.000906	CcSEcCtD
Bendroflumethiazide—Hypotension—Topiramate—epilepsy syndrome	7.97e-05	0.000893	CcSEcCtD
Bendroflumethiazide—Asthenia—Pregabalin—epilepsy syndrome	7.94e-05	0.000889	CcSEcCtD
Bendroflumethiazide—Vomiting—Valproic Acid—epilepsy syndrome	7.78e-05	0.000871	CcSEcCtD
Bendroflumethiazide—Rash—Valproic Acid—epilepsy syndrome	7.72e-05	0.000864	CcSEcCtD
Bendroflumethiazide—Dermatitis—Valproic Acid—epilepsy syndrome	7.71e-05	0.000863	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Pregabalin—epilepsy syndrome	7.57e-05	0.000847	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Topiramate—epilepsy syndrome	7.42e-05	0.000831	CcSEcCtD
Bendroflumethiazide—Dizziness—Pregabalin—epilepsy syndrome	7.32e-05	0.000819	CcSEcCtD
Bendroflumethiazide—Constipation—Topiramate—epilepsy syndrome	7.3e-05	0.000817	CcSEcCtD
Bendroflumethiazide—Asthenia—Gabapentin—epilepsy syndrome	7.28e-05	0.000815	CcSEcCtD
Bendroflumethiazide—Nausea—Valproic Acid—epilepsy syndrome	7.27e-05	0.000814	CcSEcCtD
Bendroflumethiazide—Vomiting—Pregabalin—epilepsy syndrome	7.03e-05	0.000788	CcSEcCtD
Bendroflumethiazide—Rash—Pregabalin—epilepsy syndrome	6.98e-05	0.000781	CcSEcCtD
Bendroflumethiazide—Dermatitis—Pregabalin—epilepsy syndrome	6.97e-05	0.00078	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Gabapentin—epilepsy syndrome	6.94e-05	0.000777	CcSEcCtD
Bendroflumethiazide—Dizziness—Gabapentin—epilepsy syndrome	6.71e-05	0.000751	CcSEcCtD
Bendroflumethiazide—Nausea—Pregabalin—epilepsy syndrome	6.57e-05	0.000736	CcSEcCtD
Bendroflumethiazide—Vomiting—Gabapentin—epilepsy syndrome	6.45e-05	0.000722	CcSEcCtD
Bendroflumethiazide—Rash—Gabapentin—epilepsy syndrome	6.4e-05	0.000716	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gabapentin—epilepsy syndrome	6.39e-05	0.000715	CcSEcCtD
Bendroflumethiazide—Asthenia—Topiramate—epilepsy syndrome	6.12e-05	0.000686	CcSEcCtD
Bendroflumethiazide—Nausea—Gabapentin—epilepsy syndrome	6.03e-05	0.000675	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Topiramate—epilepsy syndrome	5.84e-05	0.000654	CcSEcCtD
Bendroflumethiazide—Dizziness—Topiramate—epilepsy syndrome	5.64e-05	0.000632	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	5.55e-05	0.000797	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	5.54e-05	0.000796	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—KCNB1—epilepsy syndrome	5.47e-05	0.000785	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CACNA2D2—epilepsy syndrome	5.47e-05	0.000785	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC6A8—epilepsy syndrome	5.47e-05	0.000785	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLCO1A2—epilepsy syndrome	5.47e-05	0.000785	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PFKL—epilepsy syndrome	5.47e-05	0.000785	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Topiramate—epilepsy syndrome	5.43e-05	0.000608	CcSEcCtD
Bendroflumethiazide—Rash—Topiramate—epilepsy syndrome	5.38e-05	0.000602	CcSEcCtD
Bendroflumethiazide—Dermatitis—Topiramate—epilepsy syndrome	5.38e-05	0.000602	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	5.36e-05	0.00077	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	5.36e-05	0.00077	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—L2HGDH—epilepsy syndrome	5.22e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CERS1—epilepsy syndrome	5.22e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GLUD1—epilepsy syndrome	5.22e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PDXK—epilepsy syndrome	5.22e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADK—epilepsy syndrome	5.22e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—FAR1—epilepsy syndrome	5.22e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.14e-05	0.000738	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PPIA—epilepsy syndrome	5.11e-05	0.000733	CbGpPWpGaD
Bendroflumethiazide—Nausea—Topiramate—epilepsy syndrome	5.07e-05	0.000568	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—L2HGDH—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GLUD1—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ATIC—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—UPB1—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CERS1—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PDXK—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—FAR1—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADK—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NEU1—epilepsy syndrome	5e-05	0.000718	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HSD17B4—epilepsy syndrome	4.82e-05	0.000691	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—FAR1—epilepsy syndrome	4.8e-05	0.000688	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PDXK—epilepsy syndrome	4.8e-05	0.000688	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—L2HGDH—epilepsy syndrome	4.8e-05	0.000688	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GLUD1—epilepsy syndrome	4.8e-05	0.000688	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADK—epilepsy syndrome	4.8e-05	0.000688	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CERS1—epilepsy syndrome	4.8e-05	0.000688	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.78e-05	0.000686	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PNPO—epilepsy syndrome	4.77e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—EPM2A—epilepsy syndrome	4.77e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NHLRC1—epilepsy syndrome	4.77e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GAMT—epilepsy syndrome	4.77e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ATP2A2—epilepsy syndrome	4.67e-05	0.00067	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—NOS2—epilepsy syndrome	4.65e-05	0.000668	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPP1R3C—epilepsy syndrome	4.65e-05	0.000668	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GBE1—epilepsy syndrome	4.65e-05	0.000668	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PNPO—epilepsy syndrome	4.58e-05	0.000657	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EPM2A—epilepsy syndrome	4.58e-05	0.000657	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GAMT—epilepsy syndrome	4.58e-05	0.000657	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NHLRC1—epilepsy syndrome	4.58e-05	0.000657	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGA2—epilepsy syndrome	4.53e-05	0.00065	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—QDPR—epilepsy syndrome	4.44e-05	0.000637	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NHLRC1—epilepsy syndrome	4.39e-05	0.00063	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GAMT—epilepsy syndrome	4.39e-05	0.00063	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PNPO—epilepsy syndrome	4.39e-05	0.00063	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EPM2A—epilepsy syndrome	4.39e-05	0.00063	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ASAH1—epilepsy syndrome	4.37e-05	0.000628	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.37e-05	0.000627	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.26e-05	0.000611	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CA4—epilepsy syndrome	4.25e-05	0.000611	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—QDPR—epilepsy syndrome	4.25e-05	0.000611	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—STXBP1—epilepsy syndrome	4.25e-05	0.000611	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—COX3—epilepsy syndrome	4.17e-05	0.000599	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NT5E—epilepsy syndrome	4.15e-05	0.000595	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALAD—epilepsy syndrome	4.15e-05	0.000595	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CA4—epilepsy syndrome	4.08e-05	0.000585	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—QDPR—epilepsy syndrome	4.08e-05	0.000585	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—COX3—epilepsy syndrome	4e-05	0.000574	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ADRA2A—epilepsy syndrome	3.98e-05	0.000572	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PLAT—epilepsy syndrome	3.97e-05	0.000569	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—KCNB1—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PFKL—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALDH7A1—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CACNA2D2—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLCO1A2—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC6A8—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CACNA1A—epilepsy syndrome	3.96e-05	0.000568	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ST3GAL3—epilepsy syndrome	3.87e-05	0.000555	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—COX3—epilepsy syndrome	3.84e-05	0.00055	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—KCNB1—epilepsy syndrome	3.79e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLCO1A2—epilepsy syndrome	3.79e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CACNA2D2—epilepsy syndrome	3.79e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PFKL—epilepsy syndrome	3.79e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADSL—epilepsy syndrome	3.79e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC6A8—epilepsy syndrome	3.79e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS1—epilepsy syndrome	3.73e-05	0.000535	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GLUL—epilepsy syndrome	3.72e-05	0.000534	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CACNA1D—epilepsy syndrome	3.65e-05	0.000524	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—KCNB1—epilepsy syndrome	3.64e-05	0.000522	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLCO1A2—epilepsy syndrome	3.64e-05	0.000522	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC6A8—epilepsy syndrome	3.64e-05	0.000522	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CACNA2D2—epilepsy syndrome	3.64e-05	0.000522	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PFKL—epilepsy syndrome	3.64e-05	0.000522	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—PRKCB—epilepsy syndrome	3.62e-05	0.00052	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.62e-05	0.00052	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ATIC—epilepsy syndrome	3.62e-05	0.000519	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UPB1—epilepsy syndrome	3.62e-05	0.000519	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NEU1—epilepsy syndrome	3.62e-05	0.000519	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT3—epilepsy syndrome	3.49e-05	0.000501	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSD17B4—epilepsy syndrome	3.48e-05	0.0005	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NEU1—epilepsy syndrome	3.47e-05	0.000498	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—UPB1—epilepsy syndrome	3.47e-05	0.000498	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ATIC—epilepsy syndrome	3.47e-05	0.000498	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.46e-05	0.000496	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PLAUR—epilepsy syndrome	3.45e-05	0.000495	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TXNRD1—epilepsy syndrome	3.41e-05	0.00049	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GBE1—epilepsy syndrome	3.36e-05	0.000483	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPP1R3C—epilepsy syndrome	3.36e-05	0.000483	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.36e-05	0.000482	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSD17B4—epilepsy syndrome	3.34e-05	0.000479	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UPB1—epilepsy syndrome	3.33e-05	0.000477	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ATIC—epilepsy syndrome	3.33e-05	0.000477	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NEU1—epilepsy syndrome	3.33e-05	0.000477	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AQP1—epilepsy syndrome	3.31e-05	0.000476	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPP1R3C—epilepsy syndrome	3.22e-05	0.000463	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GBE1—epilepsy syndrome	3.22e-05	0.000463	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSD17B4—epilepsy syndrome	3.2e-05	0.000459	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CDC42—epilepsy syndrome	3.19e-05	0.000457	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ASAH1—epilepsy syndrome	3.16e-05	0.000454	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GBE1—epilepsy syndrome	3.09e-05	0.000444	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPP1R3C—epilepsy syndrome	3.09e-05	0.000444	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—JUN—epilepsy syndrome	3.09e-05	0.000443	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—STXBP1—epilepsy syndrome	3.08e-05	0.000441	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ASAH1—epilepsy syndrome	3.03e-05	0.000435	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CHRM3—epilepsy syndrome	3e-05	0.00043	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NT5E—epilepsy syndrome	3e-05	0.00043	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALAD—epilepsy syndrome	3e-05	0.00043	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—KCNJ11—epilepsy syndrome	3e-05	0.00043	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—STXBP1—epilepsy syndrome	2.95e-05	0.000423	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ASAH1—epilepsy syndrome	2.91e-05	0.000417	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NT5E—epilepsy syndrome	2.87e-05	0.000412	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALAD—epilepsy syndrome	2.87e-05	0.000412	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CACNA1A—epilepsy syndrome	2.86e-05	0.00041	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALDH7A1—epilepsy syndrome	2.86e-05	0.00041	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.84e-05	0.000408	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FYN—epilepsy syndrome	2.84e-05	0.000407	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—STXBP1—epilepsy syndrome	2.83e-05	0.000406	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.82e-05	0.000404	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ST3GAL3—epilepsy syndrome	2.8e-05	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NT5E—epilepsy syndrome	2.76e-05	0.000395	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALAD—epilepsy syndrome	2.76e-05	0.000395	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CACNA1A—epilepsy syndrome	2.74e-05	0.000393	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADSL—epilepsy syndrome	2.74e-05	0.000393	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALDH7A1—epilepsy syndrome	2.74e-05	0.000393	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.73e-05	0.000392	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—YWHAZ—epilepsy syndrome	2.73e-05	0.000391	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GLUL—epilepsy syndrome	2.69e-05	0.000386	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ST3GAL3—epilepsy syndrome	2.68e-05	0.000385	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CACNA1D—epilepsy syndrome	2.64e-05	0.000379	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALDH7A1—epilepsy syndrome	2.63e-05	0.000377	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADSL—epilepsy syndrome	2.63e-05	0.000377	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CACNA1A—epilepsy syndrome	2.63e-05	0.000377	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GLUL—epilepsy syndrome	2.58e-05	0.00037	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ST3GAL3—epilepsy syndrome	2.57e-05	0.000369	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CACNA1D—epilepsy syndrome	2.53e-05	0.000363	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADSL—epilepsy syndrome	2.52e-05	0.000362	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GLUL—epilepsy syndrome	2.47e-05	0.000355	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TXNRD1—epilepsy syndrome	2.47e-05	0.000354	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCG2—epilepsy syndrome	2.44e-05	0.000351	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CACNA1D—epilepsy syndrome	2.43e-05	0.000348	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PLAU—epilepsy syndrome	2.42e-05	0.000347	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AQP1—epilepsy syndrome	2.4e-05	0.000344	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2C19—epilepsy syndrome	2.38e-05	0.000342	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TXNRD1—epilepsy syndrome	2.37e-05	0.00034	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP11A1—epilepsy syndrome	2.37e-05	0.00034	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AQP1—epilepsy syndrome	2.3e-05	0.00033	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TXNRD1—epilepsy syndrome	2.27e-05	0.000326	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PRKCB—epilepsy syndrome	2.25e-05	0.000323	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS2—epilepsy syndrome	2.22e-05	0.000319	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AQP1—epilepsy syndrome	2.2e-05	0.000316	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—KCNJ11—epilepsy syndrome	2.17e-05	0.000311	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CHRM3—epilepsy syndrome	2.17e-05	0.000311	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2D6—epilepsy syndrome	2.14e-05	0.000306	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—KCNJ11—epilepsy syndrome	2.08e-05	0.000298	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CHRM3—epilepsy syndrome	2.08e-05	0.000298	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADRA2A—epilepsy syndrome	2.03e-05	0.000292	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—BCHE—epilepsy syndrome	2.02e-05	0.000291	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CHRM3—epilepsy syndrome	1.99e-05	0.000286	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—KCNJ11—epilepsy syndrome	1.99e-05	0.000286	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC2A1—epilepsy syndrome	1.93e-05	0.000277	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PLCB1—epilepsy syndrome	1.91e-05	0.000274	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TH—epilepsy syndrome	1.9e-05	0.000273	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—epilepsy syndrome	1.87e-05	0.000268	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCG2—epilepsy syndrome	1.77e-05	0.000254	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2C19—epilepsy syndrome	1.72e-05	0.000247	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP11A1—epilepsy syndrome	1.71e-05	0.000246	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.71e-05	0.000245	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCG2—epilepsy syndrome	1.69e-05	0.000243	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2C19—epilepsy syndrome	1.65e-05	0.000237	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP11A1—epilepsy syndrome	1.64e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCG2—epilepsy syndrome	1.62e-05	0.000233	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMOX1—epilepsy syndrome	1.59e-05	0.000228	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2C19—epilepsy syndrome	1.58e-05	0.000227	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP11A1—epilepsy syndrome	1.57e-05	0.000226	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CAT—epilepsy syndrome	1.57e-05	0.000225	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2D6—epilepsy syndrome	1.54e-05	0.000222	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCB1—epilepsy syndrome	1.53e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2D6—epilepsy syndrome	1.48e-05	0.000212	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADRA2A—epilepsy syndrome	1.47e-05	0.000211	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—BCHE—epilepsy syndrome	1.46e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2D6—epilepsy syndrome	1.42e-05	0.000204	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPX1—epilepsy syndrome	1.42e-05	0.000203	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADRA2A—epilepsy syndrome	1.41e-05	0.000202	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—BCHE—epilepsy syndrome	1.4e-05	0.000201	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC2A1—epilepsy syndrome	1.4e-05	0.0002	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PLCB1—epilepsy syndrome	1.38e-05	0.000198	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TH—epilepsy syndrome	1.38e-05	0.000197	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADRA2A—epilepsy syndrome	1.35e-05	0.000194	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—BCHE—epilepsy syndrome	1.35e-05	0.000193	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC2A1—epilepsy syndrome	1.34e-05	0.000192	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PLCB1—epilepsy syndrome	1.32e-05	0.00019	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—epilepsy syndrome	1.32e-05	0.00019	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TH—epilepsy syndrome	1.32e-05	0.000189	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—epilepsy syndrome	1.29e-05	0.000185	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC2A1—epilepsy syndrome	1.28e-05	0.000184	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PLCB1—epilepsy syndrome	1.27e-05	0.000182	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TH—epilepsy syndrome	1.27e-05	0.000182	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AGT—epilepsy syndrome	1.24e-05	0.000178	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APOE—epilepsy syndrome	1.22e-05	0.000175	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HMOX1—epilepsy syndrome	1.15e-05	0.000165	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CAT—epilepsy syndrome	1.13e-05	0.000163	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCB1—epilepsy syndrome	1.1e-05	0.000158	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMOX1—epilepsy syndrome	1.1e-05	0.000158	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CAT—epilepsy syndrome	1.09e-05	0.000156	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCB1—epilepsy syndrome	1.06e-05	0.000152	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMOX1—epilepsy syndrome	1.06e-05	0.000152	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—POMC—epilepsy syndrome	1.05e-05	0.00015	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CAT—epilepsy syndrome	1.04e-05	0.000149	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX1—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCB1—epilepsy syndrome	1.01e-05	0.000145	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX1—epilepsy syndrome	9.83e-06	0.000141	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—epilepsy syndrome	9.54e-06	0.000137	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX1—epilepsy syndrome	9.42e-06	0.000135	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AGT—epilepsy syndrome	8.99e-06	0.000129	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APOE—epilepsy syndrome	8.81e-06	0.000126	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AGT—epilepsy syndrome	8.62e-06	0.000124	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APOE—epilepsy syndrome	8.44e-06	0.000121	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—epilepsy syndrome	8.35e-06	0.00012	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AGT—epilepsy syndrome	8.26e-06	0.000119	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—epilepsy syndrome	8.22e-06	0.000118	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APOE—epilepsy syndrome	8.09e-06	0.000116	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—POMC—epilepsy syndrome	7.57e-06	0.000109	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—POMC—epilepsy syndrome	7.25e-06	0.000104	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—POMC—epilepsy syndrome	6.95e-06	9.98e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—epilepsy syndrome	6.9e-06	9.9e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—epilepsy syndrome	6.61e-06	9.49e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—epilepsy syndrome	6.34e-06	9.1e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—epilepsy syndrome	6.03e-06	8.66e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—epilepsy syndrome	5.79e-06	8.3e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—epilepsy syndrome	5.55e-06	7.96e-05	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—epilepsy syndrome	4.19e-06	6.02e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—epilepsy syndrome	3.03e-06	4.35e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—epilepsy syndrome	2.91e-06	4.17e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—epilepsy syndrome	2.79e-06	4e-05	CbGpPWpGaD
